Status: retired, Primitive. Date: 31-Jul 2018. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module | 
| 1191304018 | Irinotecan hydrochloride trihydrate 40mg/2mL infusion concentrate (product) | en | Fully specified name | Inactive | Initial character case insensitive | SNOMED CT core | 
| 1457173019 | Irinotecan hydrochloride trihydrate 20mg/mL infusion concentrate 2mL vial (product) | en | Fully specified name | Active | Initial character case insensitive | SNOMED CT core | 
| 1477701011 | Irinotecan hydrochloride trihydrate 20mg/mL infusion concentrate 2mL vial | en | Synonym | Active | Initial character case insensitive | SNOMED CT core | 
| 466695016 | Irinotecan hydrochloride trihydrate 40mg/2mL infusion concentrate | en | Synonym | Active | Initial character case insensitive | SNOMED CT core | 
| 719332017 | Irinotecan hydrochloride trihydrate 40mg/2mL infusion concentrate (substance) | en | Fully specified name | Inactive | Initial character case insensitive | SNOMED CT core | 
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values | 
| Irinotecan hydrochloride trihydrate 20mg/mL infusion concentrate 2mL vial | Is a | Irinotecan hydrochloride | false | Inferred relationship | Some | ||
| Irinotecan hydrochloride trihydrate 20mg/mL infusion concentrate 2mL vial | Is a | Irinotecan-containing product | false | Inferred relationship | Some | ||
| Irinotecan hydrochloride trihydrate 20mg/mL infusion concentrate 2mL vial | Is a | Irinotecan hydrochloride | false | Inferred relationship | Some | ||
| Irinotecan hydrochloride trihydrate 20mg/mL infusion concentrate 2mL vial | Has active ingredient | Irinotecan hydrochloride | false | Inferred relationship | Some | ||
| Irinotecan hydrochloride trihydrate 20mg/mL infusion concentrate 2mL vial | Has active ingredient | Irinotecan | false | Inferred relationship | Some | ||
| Irinotecan hydrochloride trihydrate 20mg/mL infusion concentrate 2mL vial | Has manufactured dose form | Injection | false | Inferred relationship | Some | ||
| Irinotecan hydrochloride trihydrate 20mg/mL infusion concentrate 2mL vial | Has active ingredient | Irinotecan hydrochloride | false | Inferred relationship | Some | ||
| Irinotecan hydrochloride trihydrate 20mg/mL infusion concentrate 2mL vial | Is a | Product manufactured as parenteral dose form | false | Inferred relationship | Some | ||
| Irinotecan hydrochloride trihydrate 20mg/mL infusion concentrate 2mL vial | Has manufactured dose form | Infusion concentrate | false | Inferred relationship | Some | ||
| Irinotecan hydrochloride trihydrate 20mg/mL infusion concentrate 2mL vial | Is a | Irinotecan-containing product in parenteral dose form | false | Inferred relationship | Some | 
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group | 
Reference Sets
Concept inactivation indicator reference set
REPLACED BY association reference set